Release test results
99.684%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 5.03 mg
Related impurities (total)0.316%
Endotoxin<1.0 EU/mg
HPLC retention time8.91 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundPentadecapeptide
Presentation5 MG
Lot numberRGX-25-PENTADECAPEPTIDE-628
COA numberNS-2026-05220
Test date24 Dec 2025
Release date27 Dec 2025
Independent labNordicstar Labs
StatusSuperseded
Pentadecapeptide — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-PENTADECAPEPTIDE-1072 | 5 MG | Jul 3, 2026 | 99.683% | Current |
| RGX-26-PENTADECAPEPTIDE-1073 | 10 MG | Jul 2, 2026 | 99.645% | Current |
| RGX-26-PENTADECAPEPTIDE-728 | 5 MG | Apr 1, 2026 | 99.638% | Superseded |
| RGX-26-PENTADECAPEPTIDE-727 | 10 MG | Mar 22, 2026 | 99.722% | Superseded |
| RGX-25-PENTADECAPEPTIDE-627 | 10 MG | Dec 25, 2025 | 99.608% | Superseded |
| RGX-25-PENTADECAPEPTIDE-628 this lot | 5 MG | Dec 24, 2025 | 99.684% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →